Stock Price Quote

ARVEE LABORATORIES (INDIA) LTD.

NSE : ARVEEBSE : ISIN CODE : INE006Z01016Industry : ChemicalsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE147.893.5 (+2.42 %)
PREV CLOSE( ) 144.39
OPEN PRICE ( ) 149.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2580
TODAY'S LOW / HIGH( ) 136.10 149.80
52 WK LOW / HIGH ( )126.54 235.79
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-01 2012
Management Info
Shalin Sudhakarbhai Patel - Chairman Shalin Sudhakarbhai Patel - Managing Director
Registered Office

Address 403, Entice, Nr. Jayantilal Park Brts,Iscon Bopal Road,Ambii,
Ahmedabad,
Gujarat-380058

Phone 02717-430479

Email compliance@arveelabs.com

Website www.arveelabs.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : NSE

NEWS

09May Outcome of Board Meeting
Arvee Laboratories (India) Limited has informed the Exchange regarding..
28Mar Closure of Trading Window
Arvee Laboratories (India) Limited has informed the Exchange regarding t..
12Feb Outcome of Board Meeting
Arvee Laboratories (India) Limited has informed the Exchange regarding..
12Feb Updates
Arvee Laboratories (India) Limited has submitted to the Exchange, the fi..
26Mar Arvee Laboratories sells entire stake
Arvee Laboratories has sold its 100% investment in its subsidiary compan..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit0.6921.46
Gross Profit 0.94 28.7
Operating Profit 4.3242.68
Net Sales 64.5384.87

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Polson (BSE)
peergroup  12866.50 (4.07%)
M.Cap ( in Cr)154.08
Fine Organic Inds. (BSE)
peergroup  4510.75 (4.80%)
M.Cap ( in Cr)13774.61
Solar Industries (BSE)
peergroup  13729.00 (1.03%)
M.Cap ( in Cr)124147.83
Privi Speciality Che (BSE)
peergroup  2334.35 (5.43%)
M.Cap ( in Cr)9150.05
Tanfac Industries (BSE)
peergroup  3271.65 (3.12%)
M.Cap ( in Cr)3261.83

Shareholding Pattern

PROMOTERS 73.5%
NON-INSTITUTION 26.5%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Arvee Laboratories (India) Ltd.

Arvee Laboratories (India) Ltd. was incorporated in the year 2012. Its today's share price is 0. Its current market capitalisation stands at Rs 160.93 Cr. In the latest quarter, company has reported Gross Sales of Rs. 303.45 Cr and Total Income of Rs.309.85 Cr. The company's management includes Neetu Rishi Jalan, Praveen Kumar Mishra, Shalini Hitesh Jalan, Sachin Kanwarlal Kansal, Raina Singh, Shalin Bharat Chokshi, Shalin Sudhakarbhai Patel, Shalin Sudhakarbhai Patel.

It is listed on the BSE with a BSE Code of  , NSE with an NSE Symbol of ARVEE and ISIN of INE006Z01016. It's Registered office is at 403, Entice, Nr. Jayantilal Park Brts,Iscon Bopal Road,AmbiiAhmedabad-380058, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bharatiya & Malkani, Jaimin Deliwala & Co, KCJM & Associates, Nirav Patel & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.